GlassScriptPhysician profile
Debra M Schultz
NPI 1124194279
$2,827.48
in general payments reported to CMS, 2019-2025
22 companies · $490 in 2025
The $490 reported for 2025 was more than what 76% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,297 · 2022: $441 · 2023: $193 · 2024: $406 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009 · Education: $79.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.33 |
| Education | $79.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $793.68 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $408.57 | 2021-2025 | Fasenra, Airsupra, Imfinzi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.75 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Mylan Specialty L.P. | $239.61 | 2021-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $176.43 | 2021-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $158.33 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $116.64 | 2021-2025 | Opsumit |
| Takeda Pharmaceuticals U.S.A., INC. | $84.69 | 2021-2025 | Glassia |
| Harmony Biosciences LLC | $61.61 | 2022 | |
| Philips North America LLC | $53.17 | 2021 | |
| Insmed, INC. | $52.85 | 2022-2025 | Arikayce |
| Viatris Specialty LLC | $50.91 | 2025 | Yupelri |
| Genentech USA, INC. | $44.92 | 2021-2022 | |
| Grifols USA, LLC | $37.56 | 2022-2023 | Prolastin-C Liquid |
| Nabriva Therapeutics, Plc | $37.48 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $35.43 | 2023-2025 | Smartvest |
| Inogen, INC. | $26.51 | 2025 | |
| Pulmonx Corporation | $22.74 | 2021 | |
| Baxter Healthcare | $21.39 | 2023 | Hillrom - Life 2000 Ventilation System |
| Verona Pharma, INC. | $14.30 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $13.58 | 2022 | |
| Genzyme Corporation | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.